Role of FGF21 in Breast Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

ELISA

Enzyme-Linked Immunosorbent Assay. It's a lab technique used to detect and measure specific proteins like antibodies or antigens in a biological sample using enzyme-linked antibodies. When a substrate is added, the enzyme causes a color change, which makes it easy to measure the result accurately.

Trial Locations (1)

Unknown

Assuit university ( South Egypt Cancer Institute ), Asyut

All Listed Sponsors
lead

Assiut University

OTHER